Evidence map›Paper›PMID 42540677›Full record

ReviewJournal of the advanced practitioner in oncology2026

Characteristics and Effectiveness of Targeted Melanoma Prevention Interventions for First-Degree Relatives of Melanoma Survivors: An Integrative Review.

Jennie Clark, Ashley Martinez, Joyce Dains

Abstract readReview
In one paragraph

Review in Journal of the advanced practitioner in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jennie ClarkFrom Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ashley MartinezFrom Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Joyce DainsFrom Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

First-degree relatives of melanoma survivors have at least a twofold increased risk for developing melanoma, but studies show that they do not regularly adopt sun safety behaviors. While there is no definitive method to prevent skin cancer, there are ways to dramatically reduce the risk. Determining which interventions positively impact the adoption of prevention behaviors will assist in the development of strategies to reduce the occurrence of melanoma in first-degree relatives. A literature search was conducted using PubMed and Scopus in December 2024. The search focused on studies related to first-degree relatives of melanoma survivors and included discussion of prevention interventions. Five articles were included in this integrative review. Overall, the studies found that targeted prevention interventions led to improvements in sun protective and screening behaviors in first-degree relatives. However, the effectiveness of these interventions differed, which may have depended on how the interventions were delivered to the target audience and barriers to the adoption of sun protective behaviors. Variation in educational content did not appear to impact results. However, interactive educational content delivered online that involved the entire family was the optimal intervention to foster the adoption of sun safety behaviors in first-degree relatives. This review specifically focused on first-degree relatives of melanoma survivors. However, targeted prevention interventions can be applied to other cancers, due to family history of cancer as a risk factor and the fact that family members tend to share health habits.

Identifiers

PMID42540677
PMCPMC13426388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.